Company intelligence / Profile preview

Marvel Medtech

Middleton, Wisconsin, United Statesmarvelmedtech.com ↗

Ownership: Private
Employees: ~7
Development stage: Preclinical

Overview

Marvel Medtech has developed the Solada™ iMR-IGI system, an MRI-guided robotic accessory platform designed for real-time image-guided cryoablation of suspicious breast lesions detected during MRI screening. The technology aims to enable immediate preventive treatment of early-stage or high-risk breast cancers, potentially reducing the need for biopsy, surgery, radiation, and chemotherapy. Early technical feasibility has been demonstrated in SBIR-funded projects; clinical results are pending as the product advances toward commercialization

Therapeutic areas: Oncology
Modalities: DeviceCryotherapy
Industry: Therapeutic Medical Devices

Partnerships

NIH/National Cancer Institute (grant funding)Wisconsin Economic Development Corporation/WEDC TDF loan & grants

Beyond the preview

Go deeper on Marvel Medtech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Marvel Medtech.

Explore the full profile